Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

AIM: To investigate the efficacy and safety of cape-citabine plus irinotecan ± bevacizumab in advanced or metastatic colorectal cancer patients. METHODS: Forty six patients with previously untreated, locally-advanced or metastatic colorectal cancer (mCRC) were recruited between 2001-2006 in a prospe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Moehler, Markus, Sprinzl, Martin F, Abdelfattah, Murad, Schimanski, Carl C, Adami, Bernd, Godderz, Werner, Majer, Klaus, Flieger, Dimitri, Teufel, Andreas, Siebler, Juergen, Hoehler, Thomas, Galle, Peter R, Kanzler, Stephan
Format: Artigo
Jezik:Inglês
Izdano: The WJG Press and Baishideng 2009
Teme:
Brief Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653366/
https://ncbi.nlm.nih.gov/pubmed/19152449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.449
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki